{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T02:29:07Z","timestamp":1670984947617},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s40257-016-0233-1","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T09:34:52Z","timestamp":1478597692000},"page":"127-132","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is There a Role for Opportunistic Infection Prophylaxis in Pemphigus? An Expert Survey"],"prefix":"10.1007","volume":"18","author":[{"given":"Yael A.","family":"Leshem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Snast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rivka","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihi","family":"Atzmony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assi","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmilia","family":"Hodak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mimouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"issue":"4","key":"233_CR1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","volume":"57","author":"C Chams-Davatchi","year":"2007","unstructured":"Chams-Davatchi C, Esmaili N, Daneshpazhooh M, et al. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol. 2007;57(4):622.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"233_CR2","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","volume":"130","author":"S Beissert","year":"2010","unstructured":"Beissert S, Mimouni D, Kanwar AJ, Solomons N, Kalia V, Anhalt GJ. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial. J Invest Dermatol. 2010;130(8):2041.","journal-title":"J Invest Dermatol."},{"issue":"2","key":"233_CR3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1996.03890260105016","volume":"132","author":"JC Bystryn","year":"1996","unstructured":"Bystryn JC, Steinman NM. The adjuvant therapy of pemphigus. An update. Arch Dermatol. 1996;132(2):203.","journal-title":"Arch Dermatol."},{"key":"233_CR4","first-page":"1","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KK, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58:1\u2013207.","journal-title":"MMWR Recomm Rep."},{"issue":"5","key":"233_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM197501302920504","volume":"292","author":"JJ Rinehart","year":"1975","unstructured":"Rinehart JJ, Sagone AL, Balcerzak SP, Ackerman GA, LoBuglio AF. Effects of corticosteroid therapy on human monocyte function. N Engl J Med. 1975;292(5):236.","journal-title":"N Engl J Med"},{"issue":"1","key":"233_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0167-0115(97)01063-X","volume":"73","author":"D Franchimont","year":"1998","unstructured":"Franchimont D, Louis E, Dewe W, et al. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept. 1998;73(1):59.","journal-title":"Regul Pept"},{"issue":"3","key":"233_CR7","first-page":"479","volume":"101","author":"JD Slade","year":"1983","unstructured":"Slade JD, Hepburn B. Prednisone-induced alterations of circulating human lymphocyte subsets. J Lab Clin Med. 1983;101(3):479.","journal-title":"J Lab Clin Med"},{"issue":"2","key":"233_CR8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jaad.2014.03.020","volume":"71","author":"YA Leshem","year":"2014","unstructured":"Leshem YA, Gdalevich M, Ziv M, David M, Hodak E, Mimouni D. Opportunistic infections in patients with pemphigus. J Am Acad Dermatol. 2014;71(2):284\u201392.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"233_CR9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","volume":"96","author":"KG Saag","year":"1994","unstructured":"Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994;96(2):115.","journal-title":"Am J Med"},{"key":"233_CR10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","volume":"96","author":"CN Kotton","year":"2013","unstructured":"Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96:333\u201360.","journal-title":"Transplantation"},{"key":"233_CR11","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America; 2016. http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adult_oi.pdf . Accessed 1 June 2016."},{"key":"233_CR12","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","volume":"94","author":"M Sandherr","year":"2015","unstructured":"Sandherr M, Hentrich M, von Lilienfeld-Toal M, et al. Antiviral prophylaxis in patients with solid tumours and haematological malignancies\u2013update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Ann Hematol. 2015;94:1441\u201350.","journal-title":"Ann Hematol"},{"key":"233_CR13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5414\/CNP63068","volume":"63","author":"Y Sakuma","year":"2005","unstructured":"Sakuma Y, Katoh T, Owada K, et al. Initial functional status predicts infections during steroid therapy for renal diseases. Clin Nephrol. 2005;63:68.","journal-title":"Clin Nephrol"},{"key":"233_CR14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","volume":"11","author":"AE Stuck","year":"1989","unstructured":"Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954.","journal-title":"Rev Infect Dis"},{"key":"233_CR15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/art.1780210107","volume":"21","author":"E Ginzler","year":"1978","unstructured":"Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978;21:37.","journal-title":"Arthritis Rheum"},{"key":"233_CR16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40257-014-0101-9","volume":"15","author":"L Atzmony","year":"2014","unstructured":"Atzmony L, Hodak E, Gdalevich M, Rosenbaum O, Mimouni D. Treatment of pemphigus vulgaris and pemphigus foliaceus: a systematic review and meta-analysis. Am J Clin Dermatol. 2014;15:503\u201315.","journal-title":"Am J Clin Dermatol"},{"key":"233_CR17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0891-5520(05)70154-9","volume":"15","author":"NC Klein","year":"2001","unstructured":"Klein NC, Go CH, Cunha BA. Infections associated with steroid use. Infect Dis Clin N Am. 2001;15:423\u201332.","journal-title":"Infect Dis Clin N Am"},{"issue":"11","key":"233_CR18","doi-asserted-by":"crossref","first-page":"e78699","DOI":"10.1371\/journal.pone.0078699","volume":"8","author":"K Migita","year":"2013","unstructured":"Migita K, Sasaki Y, Ishizuka N, et al. Rates of serious intracellular infections in autoimmune disease patients receiving initial glucocorticoid therapy. PLoS One. 2013;8(11):e78699.","journal-title":"PLoS One"},{"key":"233_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0190-9622(82)70111-2","volume":"7","author":"AR Ahmed","year":"1982","unstructured":"Ahmed AR, Moy R. Death in pemphigus. J Am Acad Dermatol. 1982;7:221\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"233_CR20","doi-asserted-by":"crossref","unstructured":"Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP)in non HIV immunocompromised patients. Cochrane Database Syst Rev. 2014;(10):CD005590.","DOI":"10.1002\/14651858.CD005590.pub3"},{"key":"233_CR21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archinte.1983.00350040101013","volume":"143","author":"RA Smego Jr","year":"1983","unstructured":"Smego RA Jr, Moeller MB, Gallis HA. Trimethoprim-sulfamethoxazole therapy for nocardia infections. Arch Intern Med. 1983;143:711\u20138.","journal-title":"Arch Intern Med"},{"key":"233_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/clinids\/8.3.427","volume":"8","author":"PG Spitzer","year":"1986","unstructured":"Spitzer PG, Hammer SM, Karchmer AW. Treatment of Listeria monocytogenes infection with trimethoprim-sulfamethoxazole: case report and review of the literature. Rev Infect Dis. 1986;8:427\u201330.","journal-title":"Rev Infect Dis"},{"key":"233_CR23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00005792-198005000-00002","volume":"59","author":"BD Kirby","year":"1980","unstructured":"Kirby BD, Snyder K, Meyer R, Finegold SM. Legionnaires\u2019 disease: report of 65 nosocomially acquired cases and a review of the literature. Medicine. 1980;59:188\u2013205.","journal-title":"Medicine."},{"key":"233_CR24","first-page":"22","volume":"8","author":"KT Amber","year":"2016","unstructured":"Amber KT. Balancing the risks and benefits of prophylaxis: a reply to \u201cPneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions\u201d. Int J Dermatol. 2016;8:22.","journal-title":"Int J Dermatol"},{"key":"233_CR25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaad.2009.11.588","volume":"63","author":"JS Lehman","year":"2010","unstructured":"Lehman JS, Kalaaji AN. Role of primary prophylaxis for pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune-mediated dermatologic conditions. J Am Acad Dermatol. 2010;63:815\u201323.","journal-title":"J Am Acad Dermatol"},{"key":"233_CR26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1365-4632.2010.04857.x","volume":"50","author":"F Li","year":"2011","unstructured":"Li F, Jin H-Z, Su F, Jia L, Sun QN. Pneumocystis pneumonia in patients with immunobullous dermatoses. Int J Dermatol. 2011;50:1144\u20139.","journal-title":"Int J Dermatol"},{"key":"233_CR27","doi-asserted-by":"crossref","unstructured":"Gonzalez Santiago TM, Wetter DA, Kalaaji AN, Limper AH, Lehman JS. Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis. Int J Dermatol. 2016;55(8):823\u201330.","DOI":"10.1111\/ijd.13231"},{"key":"233_CR28","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","volume":"365","author":"EM Hodson","year":"2005","unstructured":"Hodson EM, Jones CA, Webster AC, et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomized controlled trials. Lancet. 2005;365:2105\u201315.","journal-title":"Lancet"},{"key":"233_CR29","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/bjd.13355","volume":"171","author":"PJ Keith","year":"2014","unstructured":"Keith PJ, Wetter DA, Wilson JW, Lehman JS. Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses. Br J Dermatol. 2014;171:1307\u201317.","journal-title":"Br J Dermatol"},{"key":"233_CR30","unstructured":"World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: WHO; 2015."},{"key":"233_CR31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63:261\u201383.","journal-title":"Hepatology"},{"key":"233_CR32","volume-title":"Guidelines on the management of latent tuberculosis","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis. Geneva: WHO; 2015."},{"key":"233_CR33","doi-asserted-by":"crossref","unstructured":"Mosca M, Tani C, Aringer M, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010;69(7):1269\u201374.","DOI":"10.1136\/ard.2009.117200"},{"key":"233_CR34","doi-asserted-by":"crossref","unstructured":"Laniosz V, Lehman JS, Poland GA, Wetter DA. Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses. Int J Dermatol. 2016;55(6):599\u2013607.","DOI":"10.1111\/ijd.13140"},{"key":"233_CR35","doi-asserted-by":"crossref","unstructured":"Lehman JS, el-Azhary RA. Kaposi varicelliform eruption in patients with autoimmune bullous dermatoses. Int J Dermatol. 2016;55(3):e136\u201340.","DOI":"10.1111\/ijd.13091"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-016-0233-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-016-0233-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:03:31Z","timestamp":1498359811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-016-0233-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["233"],"URL":"https:\/\/doi.org\/10.1007\/s40257-016-0233-1","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]}}}